38 related articles for article (PubMed ID: 24180274)
21. QSAR and docking based semi-synthesis and in vitro evaluation of 18 β-glycyrrhetinic acid derivatives against human lung cancer cell line A-549.
Yadav DK; Kalani K; Khan F; Srivastava SK
Med Chem; 2013 Dec; 9(8):1073-84. PubMed ID: 23675978
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and Anticancer Activities of Glycyrrhetinic Acid Derivatives.
Li Y; Feng L; Song ZF; Li HB; Huai QY
Molecules; 2016 Feb; 21(2):. PubMed ID: 26861280
[TBL] [Abstract][Full Text] [Related]
23. 2D- and 3D-QSAR modelling, molecular docking and
Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of triazole linked glycosylated 18β-glycyrrhetinic acid derivatives as anticancer agents.
Parida PK; Sau A; Ghosh T; Jana K; Biswas K; Raha S; Misra AK
Bioorg Med Chem Lett; 2014 Aug; 24(16):3865-8. PubMed ID: 25027936
[TBL] [Abstract][Full Text] [Related]
25. Design and Synthesis of New Anticancer Glycyrrhetinic Acids and Oleanolic Acids.
Wang R; Zheng QX; Wang W; Feng L; Li HJ; Huai QY
Biol Pharm Bull; 2017; 40(5):703-710. PubMed ID: 28458357
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and in vitro evaluation of 18β-glycyrrhetinic acid derivatives for anticancer activity against human breast cancer cell line MCF-7.
Yadav DK; Kalani K; Singh AK; Khan F; Srivastava SK; Pant AB
Curr Med Chem; 2014; 21(9):1160-70. PubMed ID: 24180274
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic potential of glycyrrhetinic acids: a patent review (2010-2017).
Hussain H; Green IR; Shamraiz U; Saleem M; Badshah A; Abbas G; Rehman NU; Irshad M
Expert Opin Ther Pat; 2018 May; 28(5):383-398. PubMed ID: 29558289
[TBL] [Abstract][Full Text] [Related]
28. An Overview of Structurally Modified Glycyrrhetinic Acid Derivatives as Antitumor Agents.
Xu B; Wu GR; Zhang XY; Yan MM; Zhao R; Xue NN; Fang K; Wang H; Chen M; Guo WB; Wang PL; Lei HM
Molecules; 2017 Jun; 22(6):. PubMed ID: 28574470
[TBL] [Abstract][Full Text] [Related]
29. Glycyrrhetinic Acid and Its Derivatives: Anti-Cancer and Cancer Chemopreventive Properties, Mechanisms of Action and Structure- Cytotoxic Activity Relationship.
Roohbakhsh A; Iranshahy M; Iranshahi M
Curr Med Chem; 2016; 23(5):498-517. PubMed ID: 26758798
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationship analyses of glycyrrhetinic acid derivatives as anticancer agents.
Lallemand B; Gelbcke M; Dubois J; Prévost M; Jabin I; Kiss R
Mini Rev Med Chem; 2011 Sep; 11(10):881-7. PubMed ID: 21762107
[TBL] [Abstract][Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
